Abstract
A 43-year-old patient with recurrent acute myeloid leukemia (AML) was treated with high-dose cytarabine. After two weeks of neutropenic fever, multiple cutaneous nodules appeared. Histopathological examination of a skin biopsy showed a mycosis and Fusarium solani was cultured. Despite antimycotic therapy, the patient died due to complications of his AML treatment.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adult
-
Cytarabine / adverse effects*
-
Cytarabine / therapeutic use
-
Dermatomycoses / complications*
-
Fatal Outcome
-
Fusarium
-
Humans
-
Immunocompromised Host
-
Immunosuppressive Agents / adverse effects*
-
Immunosuppressive Agents / therapeutic use
-
Leukemia, Myeloid, Acute / drug therapy
-
Leukemia, Myeloid, Acute / immunology*
-
Male
-
Neutropenia
-
Opportunistic Infections / complications*
Substances
-
Immunosuppressive Agents
-
Cytarabine